Wird geladen...

Predicting circulating CA125 levels among healthy premenopausal women

BACKGROUND: CA125 is the most promising ovarian cancer screening biomarker to date. Multiple studies reported CA125 levels vary by personal characteristics, which could inform personalized CA125 thresholds. However, this has not been well described in premenopausal women. METHODS: We evaluated predi...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cancer Epidemiol Biomarkers Prev
Hauptverfasser: Sasamoto, Naoko, Babic, Ana, Rosner, Bernard A., Fortner, Renée T., Vitonis, Allison F., Yamamoto, Hidemi, Fichorova, Raina N., Tjønneland, Anne, Hansen, Louise, Overvad, Kim, Kvaskoff, Marina, Fournier, Agnès, Romana Mancini, Francesca, Boeing, Heiner, Trichopoulou, Antonia, Peppa, Eleni, Karakatsani, Anna, Palli, Domenico, Pala, Valeria, Mattiello, Amalia, Tumino, Rosario, Grasso, Chiara C., Onland-Moret, N. Charlotte, Weiderpass, Elisabete, Quirós, J. Ramón, Lujan-Barroso, Leila, Rodríguez-Barranco, Miguel, Colorado-Yohar, Sandra, Barricarte, Aurelio, Dorronsoro, Miren, Idahl, Annika, Lundin, Eva, Sartor, Hanna, Khaw, Kay-Tee, Key, Timothy J, Muller, David, Riboli, Elio, Gunter, Marc J., Dossus, Laure, Kaaks, Rudolf, Cramer, Daniel W., Tworoger, Shelley S., Terry, Kathryn L.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2019
Schlagworte:
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6548604/
https://ncbi.nlm.nih.gov/pubmed/30948451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1055-9965.EPI-18-1120
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!